Pinaki Biswas, Ph.D. - Publications

Affiliations: 
2007 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
organometallic and heterocyclic chemistry

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Winthrop KL, Wouters A, Choy EH, Chen C, Biswas P, Wang L, Soma K, Needle E, Valdez H, Rigby WF. Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib. Annals of the Rheumatic Diseases. PMID 32161057 DOI: 10.1136/Annrheumdis-2019-216566  0.323
2019 Charles-Schoeman C, DeMasi R, Valdez H, Soma K, Hwang LJ, Boy MG, Biswas P, McInnes IB. Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31385441 DOI: 10.1002/Art.40911  0.308
2018 Mease PJ, Kremer J, Cohen S, Curtis JR, Charles-Schoeman C, Loftus EV, Greenberg J, Palmetto N, Kanik KS, Graham D, Wang C, Biswas P, Chan G, DeMasi R, Valdez H, et al. SAT0243 Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes Annals of the Rheumatic Diseases. 77: 983-983. DOI: 10.1136/Annrheumdis-2018-Eular.3048  0.308
2017 Winthrop KL, Wouters A, Choy E, Soma K, Hodge J, Nduaka C, Biswas P, Needle E, Passador S, Mojcik C, Rigby W. The Safety and Immunogenicity of Live Zoster Vaccination in Rheumatoid Arthritis Patients Before Starting Tofacitinib: A Randomized Phase II Trial. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28845577 DOI: 10.1002/Art.40187  0.306
2017 Curtis J, Yun H, FitzGerald O, Winthrop K, Azevedo V, Burmester G, Rigby W, Kanik K, Rojo R, Menon S, Wang C, Biswas P, Hendrikx T, Palmetto N. FRI0496 Comparing tofacitinib safety profile in patients with psoriatic arthritis in clinical studies with real-world data Annals of the Rheumatic Diseases. 76: 676-676. DOI: 10.1136/Annrheumdis-2017-Eular.2448  0.323
2017 Winthrop K, Wouters A, Choy E, Nduaka C, Biswas P, Wang L, Hodge J, Lazariciu I, Soma K, Mojcik C, Rigby W. OP0230 The effectiveness of zoster vaccine in RA patients subsequently treated with TOFACITINIB Annals of the Rheumatic Diseases. 76: 148-149. DOI: 10.1136/Annrheumdis-2017-Eular.2437  0.313
2015 Shorr AF, Puzniak LA, Biswas P, Niederman MS. Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP). Plos One. 10: e0131932. PMID 26196695 DOI: 10.1371/Journal.Pone.0131932  0.316
2014 Puzniak LA, Capitano B, Biswas P, Lodise TP. Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysis. Diagnostic Microbiology and Infectious Disease. 78: 295-301. PMID 24359932 DOI: 10.1016/J.Diagmicrobio.2013.11.001  0.304
2012 Itani KM, Biswas P, Reisman A, Bhattacharyya H, Baruch AM. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis. Clinical Therapeutics. 34: 1667-73.e1. PMID 22770644 DOI: 10.1016/J.Clinthera.2012.06.018  0.336
2008 Schuster MG, Edwards JE, Sobel JD, Darouiche RO, Karchmer AW, Hadley S, Slotman G, Panzer H, Biswas P, Rex JH. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Annals of Internal Medicine. 149: 83-90. PMID 18626047 DOI: 10.7326/0003-4819-149-2-200807150-00004  0.334
2008 Biswas P, Kalbfleisch JD. A risk-adjusted CUSUM in continuous time based on the Cox model. Statistics in Medicine. 27: 3382-406. PMID 18288785 DOI: 10.1002/Sim.3216  0.502
2008 Biswas P, Kalbfleisch JD. Erratum: A risk-adjusted CUSUM in continuous time based on the Cox model (Statistics in Medicine DOI: 10.1002/sim.3216) Statistics in Medicine. 27. DOI: 10.1002/Sim.3296  0.49
2006 Mikol DD, Ditlow C, Usatin D, Biswas P, Kalbfleisch J, Milner A, Calenoff E. Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients. Journal of Neuroimmunology. 180: 40-9. PMID 16996143 DOI: 10.1016/J.Jneuroim.2006.06.030  0.475
2004 Mukhopadhyay G, Mondal D, Biswas P, Dewanji A. Water quality monitoring of tropical ponds: Location and depth effect in two case studies Acta Hydrochimica Et Hydrobiologica. 32: 138-148. DOI: 10.1002/aheh.200300524  0.495
Show low-probability matches.